SCHEMBL2826858

SCHEMBL2826858

Brc1c(-c2ccccc2)[nH]c2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 4/20 0.61
▸ ESR2 Q92731 4/20 0.61
▸ CYP19A1 P11511 1/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.50
▸ ALDH1A1 P00352 3/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ GPR3 P46089 1/20 0.48
▸ HTR2A P28223 3/20 0.47
▸ KCNH2 Q12809 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HTR2C P28335 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ EGFR P00533 1/20 0.46
▸ CTSV O60911 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4276835 0.80 ESR1 (0.41) ESR1ESR2CYP19A1NPSR1ALDH1A1
SCHEMBL11656506 0.80 ALDH1A1 (0.53) CYP19A1ALDH1A1HSD17B10HTR2AKCNH2
SCHEMBL31047669 0.78 SERPINE1 (0.65) ESR1ESR2NPSR1ALDH1A1HSD17B10
SCHEMBL18787054 0.77 ESR1 (0.87) ESR1ESR2CYP19A1NPSR1ALDH1A1
SCHEMBL29799621 0.76 ESR1 (1.00) ESR1ESR2CYP19A1ALDH1A1HTR2A
SCHEMBL3864662 0.76 ESR1 (1.00) ESR1ESR2CYP19A1ALDH1A1HTR2A
SCHEMBL3929385 0.76 ESR1 (0.63) ESR1ESR2CYP19A1NPSR1ALDH1A1
SCHEMBL27293850 0.76 ESR1 (0.63) ESR1ESR2CYP19A1NPSR1ALDH1A1
SCHEMBL18154508 0.75 ESR1 (0.79) ESR1ESR2EGFRPTGS2
SCHEMBL29206325 0.75 MAPT (0.65) ESR1ESR2NPSR1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109336924-B Method for catalyzing green cyanation of halogenated aromatic hydrocarbon by supported Pd complex 大连理工大学 2021-01-19 — — CN claimed
CN-109336924-B Method for catalyzing green cyanation of halogenated aromatic hydrocarbon by supported Pd complex 大连理工大学 2021-01-19 — — CN disclosed
CN-104725296-B Indole derivatives and its application in field of organic electroluminescence 北京鼎材科技有限公司 2019-11-29 — — CN disclosed
US-10246414-B2 Allosteric modulators of CB1 cannabinoid receptors NORTHEASTERN UNIVERSITY (US) 2019-04-02 — — US disclosed
EP-2800569-B1 ALLOSTERIC MODULATORS OF CB1 CANNABINOID RECEPTORS UNIV NORTHEASTERN (US) 2018-07-25 — — EP disclosed
US-20170197918-A1 Allosteric Modulators of CB1 Cannabinoid Receptors NORTHEASTERN UNIVERSITY 2017-07-13 — — US disclosed
US-20170197918-A1 Allosteric Modulators of CB1 Cannabinoid Receptors NORTHEASTERN UNIVERSITY 2017-07-13 — — US disclosed
US-20170197918-A1 Allosteric Modulators of CB1 Cannabinoid Receptors NORTHEASTERN UNIVERSITY 2017-07-13 — — US disclosed
US-9556118-B2 Allosteric modulators of CB1 cannabinoid receptors NORTHEASTERN UNIVERSITY (US) 2017-01-31 — — US disclosed
US-9556118-B2 Allosteric modulators of CB1 cannabinoid receptors NORTHEASTERN UNIVERSITY (US) 2017-01-31 — — US disclosed
EP-2253315-A1 Alkoxyphenylpropanoic acid derivatives Takeda Pharmaceutical Company Limited (JP) 2010-11-24 — — EP disclosed
US-7786165-B2 Aminophenylpropanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-31 — — US disclosed
US-7517910-B2 Alkoxyphenylpropanoic acid derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-04-14 — — US disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 — — US disclosed
US-20070213364-A1 Alkoxyphenylpropanoic Acid Derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-09-13 — — US disclosed
EP-1731505-A1 ALKOXYPHENYLPROPANOIC ACID DERIVATIVES Takeda Pharmaceutical Company Limited (JP) 2006-12-13 — — EP disclosed
EP-1726580-A1 AMINOPHENYLPROPANOIC ACID DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2006-11-29 — — EP disclosed
EP-1303508-A1 SUBSTITUTED 1-(4-AMINOPHENYL)INDOLES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2003-04-23 — — EP disclosed
US-6353007-B1 ANTIINFLAMMATORY AGENTS AND INHIBITORS OF CELLULAR POLIFERATION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-03-05 — — US disclosed
WO-2002006273-A1 SUBSTITUTED 1-(4-AMINOPHENYL)INDOLES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2002-01-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10246414-B2 Allosteric modulators of CB1 cannabinoid receptors CNR1, CNR2, GPR18 ESR1 726/4885ESR2 723/4885CYP19A1 2487/4885
US-20070213364-A1 Alkoxyphenylpropanoic Acid Derivatives GPR119, FFAR1, GPR55 ESR1 357/4885ESR2 932/4885CYP19A1 842/4885
US-20080269220-A1 Aminophenylpropanoic Acid Derivative GPR119, GPR55, GPR65 ESR1 358/4885ESR2 733/4885CYP19A1 576/4885
US-20170197918-A1 Allosteric Modulators of CB1 Cannabinoid Receptors CNR1, CNR2, GPR18 ESR1 726/4885ESR2 723/4885CYP19A1 2487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback